Alternative Search Engine

Novelion Therapeutics: Recent Licensing Deal Reignites The Stock And Has Me Debating A Buy

https://seekingalpha.com/article/4240320-novelion-therapeutics-recent-licensing-deal-reignites-stock-debating-buy
See More From: seekingalpha.com   ( Money & Markets > Investments > Stocks )

Feb 12, 2019 3:58 PM 2+ mon ago

To ensure this doesn't happen in ...

Read More

General Dynamics' Recent Acquisition, Dividend History, And Valuation Make The Stock A Compelling Buy

seekingalpha.com     7+ mon ago

General Dynamics' Recent Acquisition, Dividend History, And Valuation Make The Stock A Compelling Buy Sep. 14, 2018 1:18 PM ET...

Biogen to buy Nightstar Therapeutics in a $800 million cash deal

Biogen to buy Nightstar Therapeutics in a $800 million cash deal

cnbc.com     1+ mon ago

Biogen said on Monday it will buy Nightstar Therapeutics for about $800 million in cash as the company looks to tap into a potentially lucrative gene therapy market. Gene therapy,...

Fate Therapeutics: Buy The Dip

seekingalpha.com     5+ mon ago

To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

Cara Therapeutics Inks Distribution Deal, Stock Will Push Higher

seekingalpha.com     6+ mon ago

To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

What Does United Therapeutics' Most Recent Deal Mean To MannKind?

seekingalpha.com     5+ mon ago

To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

Akebia Therapeutics: Still A Buy Post-Merger

seekingalpha.com     4+ week ago

The start of 2019 has seen a nice recovery, but there is still a bit more to go just to get back to the pre-merger price. The long-term commercial prospects of Auryxia and vadadustat remain unchanged...

Chevron to buy Anadarko Petroleum in a $33 billion cash and stock deal

Chevron to buy Anadarko Petroleum in a $33 billion cash and stock deal

cnbc.com     1+ week ago

Chevron on Friday announced plans to acquire oil and gas producer Anadarko Petroleum in a cash and stock deal the company valued at $33 billion. The deal values Anadarko at $65 pe...

Aclaris Therapeutics: A Promising Dermatology Buy In 2018

seekingalpha.com     4+ mon ago

To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

After The Recent Pullback, Raytheon Is A Buy

seekingalpha.com     5+ mon ago

To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

PayPal Remains A 'Buy The Dip' Stock

seekingalpha.com     6+ mon ago

To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

A Sports Hijab Has France Debating the Muslim Veil, Again

A Sports Hijab Has France Debating the Muslim Veil, Again

nytimes.com     1+ mon ago

PARIS -- Plans by a major sporting goods company in France to sell a hijab designed for runners have incited yet another debate over what Muslim women wear, exposing once again the...

Chesapeake Energy to buy WildHorse in $4B cash and stock deal

seekingalpha.com     5+ mon ago

To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

Hasbro and Wizkids Announce Enhanced Licensing Deal

Hasbro and Wizkids Announce Enhanced Licensing Deal

bleedingcool.com     1+ mon ago

WizKids, the industry leader in high quality pre-painted & unpainted miniatures and established board games, announced a new licensing partnership with Hasbro today with the additi...

UPDATE 2-Biogen to buy Nightstar Therapeutics in $800 mln cash deal

reuters.com     1+ mon ago

(Reuters) - Biogen Inc said on Monday it will buy Nightstar Therapeutics Plc for about $800 million in cash as the company looks to tap into a potentially lucrative gene therapy market. Gene therapy,...

Sarepta Therapeutics CEO on soaring stock and drug development

cnbc.com     7+ mon ago

SEARCH QUOTES To view this site, you need to have JavaScript enabled in your browser, and either the Flash Plugin or an HTML5-Video enabled browser. Download the latest Flash player and try again. ...

Anika Therapeutics Is A Solid Buy In October 2018

seekingalpha.com     6+ mon ago

To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

Proteostasis Therapeutics Delivered 400% Stock Returns

seekingalpha.com     6+ mon ago

To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

Stemline Therapeutics Has The 'Big Mo'

seekingalpha.com     1+ mon ago

We take an in-depth look at Stemline Therapeutics whose stock rose just over 15% in trading last week. Several analysts reiterated Buy ratings on Stemline last week and the company recently had ELZON...

Bristol-Myers Squibb to buy Celgene in a cash and stock deal worth $74 billion

abcnews.go.com     3+ mon ago

Bristol-Myers Squibb to buy Celgene in a cash and stock deal worth $74 billion. ...

Bristol-Myers Squibb to buy Celgene in a cash and stock deal worth $74 billion

washingtontimes.com     3+ mon ago

In this Friday, Jan. 18, 2019, file image made from video provided by the Survival Media Agency, Nick Sandmann, wearing a "Make America Great Again" hat, center left, stands in front of Native America...

Bristol-Myers Squibb to buy Celgene in a cash and stock deal worth $74 billion

seattletimes.com     3+ mon ago

Bristol-Myers Squibb to buy Celgene in a cash and stock deal worth $74 billion ...

Bristol-Myers Squibb to buy Celgene in a cash and stock deal worth $74 billion

Bristol-Myers Squibb to buy Celgene in a cash and stock deal worth $74 billion

chron.com     3+ mon ago

Stephen F. Austin long snapper Chris Wilkerson invited to Texans' Lionel Richie is kicking off his Hello Tour in Sugar Land If you feel the address you entered is correct you can...

Institutional Investors Are Buying MiMedx Again As The Stock Has Had A Nice Recent Pullback

seekingalpha.com     1+ day ago

News about the former CEO Pete Petit is not enough of a reason to justify the recent sell-off in MiMedx stock. Recent institutional buy-ins portend a possible turnaround in sentiment for the stock as...

Menlo Therapeutics: Buy, Sell Or Hold?

seekingalpha.com     3+ mon ago

To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

Marker Therapeutics: Buy, Sell, Or Hold?

seekingalpha.com     3+ mon ago

To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

Is Nike Still A Buy After The Recent Runup?

seekingalpha.com     6+ mon ago

...

If You Want To Buy TG Therapeutics, Buy Now

seekingalpha.com     1+ mon ago

To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

Review: She s Still Debating What the Constitution Means to Me

nytimes.com     6+ mon ago

Within the anxiety dream of a lecture hall that is the setting for "What the Constitution Means to Me" -- the agreeably baggy and highly topical performance piece that opened Sunday night at the New Y...

Esperion Therapeutics: Buy, Sell Or Hold?

seekingalpha.com     3+ mon ago

To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

Fiserv to buy First Data in a $22 billion all-stock deal

Fiserv to buy First Data in a $22 billion all-stock deal

cnbc.com     3+ mon ago

U.S. financial technology provider Fiserv said on Wednesday it will buy payment processor First Data in a $22 billion deal, making it one of the largest acquisitions in the financi...

Debating AOC and Green New Deal from different sides

msnbc.com     3+ mon ago

Professor Eddie Glaude Jr. and Commentary editor Noah Rothman debate freshman congresswoman Alexandria Ocasio-Cortez, the Green New Deal, Medicare-for-all and how to pay for it.Jan. 7, 2019 ...

SiriusXM to buy Pandora in $3.5 bln stock deal

dailymail.co.uk     7+ mon ago

Pandora shareholders will receive a fixed-exchange ratio of 1.44 newly-issued SiriusXM shares for each share they hold. The implied price of Pandora common ...

Search Builder

(Click to add to search box)
**Content contained on this site is provided on an “as is” basis. 4Internet, LLC makes no commitments regarding the content and does not review it, so don't assume that it's been reviewed. What you see here may not be accurate and should not be relied upon. The content does not necessarily represent the views and opinions of 4Internet, LLC. You use this service and everything you see here at your own risk. Content displayed may be subject to copyright. Content is removed on a case by case basis. To request that content be removed, contact us using the following form: Contact Us.